高等学校化学学报 ›› 2022, Vol. 43 ›› Issue (2): 20210663.doi: 10.7503/cjcu20210663
收稿日期:
2021-09-13
出版日期:
2022-02-10
发布日期:
2021-11-26
通讯作者:
王学元
E-mail:xueyuan.w@163.com
基金资助:
LI Jing1, SU Wei1, WANG Xueyuan2(), FU Peng1, SUN Yan3
Received:
2021-09-13
Online:
2022-02-10
Published:
2021-11-26
Contact:
WANG Xueyuan
E-mail:xueyuan.w@163.com
Supported by:
摘要:
建立了降压药阿雷地平新的合成路线, 并讨论了新合成方法的优化条件, 反应整体收率提高了20%; 结合阿雷地平的结构特点和合成工艺分析出6种杂质, 并提供了其制备方法和表征结果; 采用高效液相色谱(HPLC)法测定阿雷地平中的相关杂质, 为其质量标准的制定提供了实验依据.
中图分类号:
TrendMD:
李晶, 苏伟, 王学元, 傅鹏, 孙艳. 降压药阿雷地平及其相关杂质的合成与表征. 高等学校化学学报, 2022, 43(2): 20210663.
LI Jing, SU Wei, WANG Xueyuan, FU Peng, SUN Yan. Synthesis and Characterization of Antihypertensive Drug Aranidipine and Its Related Impurities. Chem. J. Chinese Universities, 2022, 43(2): 20210663.
Reagent | Time/h | Solvent | Yield(%) | Purity(%) |
---|---|---|---|---|
TFA | 20 | DCM | 80.15 | 95.23 |
H2SO4 | 8 | DCM | 64.53 | 77.33 |
FA | 5 | — | 78.27 | 73.31 |
Table 1 Optimization of reaction conditions of compound 5
Reagent | Time/h | Solvent | Yield(%) | Purity(%) |
---|---|---|---|---|
TFA | 20 | DCM | 80.15 | 95.23 |
H2SO4 | 8 | DCM | 64.53 | 77.33 |
FA | 5 | — | 78.27 | 73.31 |
Reagent | Time/h | Solvent | Yield(%) | Purity(%) |
---|---|---|---|---|
MnO2 | 2 | PhMe | 90.65 | 96.99 |
(NH4)2S2O8 | 5 | DMK/H2O | 84.03 | 93.27 |
FeCl3?6H2O | 24 | HOAc | 58.54 | 85.44 |
Table 2 Optimization of reaction conditions for oxidization of Ara-ox Ⅰ
Reagent | Time/h | Solvent | Yield(%) | Purity(%) |
---|---|---|---|---|
MnO2 | 2 | PhMe | 90.65 | 96.99 |
(NH4)2S2O8 | 5 | DMK/H2O | 84.03 | 93.27 |
FeCl3?6H2O | 24 | HOAc | 58.54 | 85.44 |
n(5)∶n(acetol) | Time/h | Yield(%) |
---|---|---|
1∶1 | 5 | 65.5 |
1∶1.2 | 5 | 70.22 |
1∶1.3 | 4 | 74.41 |
1∶1.4 | 4 | 75.22 |
1∶1.5 | 4 | 75.21 |
Table 3 Optimization of reaction conditions of aranidipine
n(5)∶n(acetol) | Time/h | Yield(%) |
---|---|---|
1∶1 | 5 | 65.5 |
1∶1.2 | 5 | 70.22 |
1∶1.3 | 4 | 74.41 |
1∶1.4 | 4 | 75.22 |
1∶1.5 | 4 | 75.21 |
tR/min | Resolution | [M+H]+, m/z | Formula | M | Compd. |
---|---|---|---|---|---|
6.74 | 3.15 | 403.11 | C19H18N2O8 | 402.11 | Ara?ox Ⅲ |
8.71 | 0.94 | 250.07 | C12H11NO5 | 249.06 | Ara?1 |
12.44 | 1.99 | 387.12 | C19H18N2O7 | 386.11 | Ara?ox Ⅰ |
14.30 | 1.99 | 333.11 | C16H16N2O6 | 332.10 | Ara?acid |
15.56 | 1.19 | 371.12 | C19H18N2O6 | 370.12 | Ara?ox Ⅱ |
19.52 | 3.22 | 389.13 | C19H20N2O7 | 388.13 | Aranidipine |
31.47 | 1.34 | 347.12 | C17H18N2O6 | 346.12 | Ara?bis |
Table 4 System assessment of HPLC and mass spectral data of aranidipine and its impurities
tR/min | Resolution | [M+H]+, m/z | Formula | M | Compd. |
---|---|---|---|---|---|
6.74 | 3.15 | 403.11 | C19H18N2O8 | 402.11 | Ara?ox Ⅲ |
8.71 | 0.94 | 250.07 | C12H11NO5 | 249.06 | Ara?1 |
12.44 | 1.99 | 387.12 | C19H18N2O7 | 386.11 | Ara?ox Ⅰ |
14.30 | 1.99 | 333.11 | C16H16N2O6 | 332.10 | Ara?acid |
15.56 | 1.19 | 371.12 | C19H18N2O6 | 370.12 | Ara?ox Ⅱ |
19.52 | 3.22 | 389.13 | C19H20N2O7 | 388.13 | Aranidipine |
31.47 | 1.34 | 347.12 | C17H18N2O6 | 346.12 | Ara?bis |
Positiona | Aranidipineb | Ara?ox Ⅰb | Ara?ox Ⅱb | Ara?ox Ⅲb | Ara?cidc | Ara?bisb | Ara?1b |
---|---|---|---|---|---|---|---|
3 | 6.50(s, 1H) | ― | ― | ― | 8.96(s, 1H) | 5.99(s, 1H) | 2.51(s, 3H) |
4 | ― | ― | ― | ― | ― | ― | 8.25(dd, 1H) |
6 | 5.68(s, 1H) | ― | ― | ― | 5.00(s, 1H) | 5.73(s, 1H) | 7.60(dddd, 1H) |
7 | 2.23(s, 3H) | 2.58(s, 3H) | 2.60(s, 3H) | 2.53(s, 3H) | 2.29(d, 3H) | 2.34(s, 3H) | 7.48—7.41(m, 1H) |
8 | 2.27(s, 3H) | 2.68(s, 3H) | 2.71(s, 3H) | 2.65(s, 3H) | 2.29(d, 3H) | 2.34(s, 3H) | 8.10(s, 1H) |
10 | 3.50(s, 3H) | 3.42(s, 3H) | 3.31(s, 3H) | 3.44(s, 3H) | 3.56(s, 3H) | 3.60(s, 3H) | 7.68(td, 1H) |
12 | 7.45(dd, J=7.9, 1.6 Hz, 1H) | 8.13(dd, 1H) | 7.65(td, 1H) | 7.57(dt, 1H) | 7.97(m, 1H) | 7.58(m, 1H) | 3.62(s, 3H) |
13 | 7.40(td, J=8.0, 7.5, 1.4 Hz, 1H) | 7.50(td, 1H) | 7.48(dd, 1H) | 7.57(dt, 1H) | 7.60(dt, 1H) | 7.41(m, 1H) | ― |
14 | 7.22—7.14(m, 1H) | 7.17(dd, 1H) | 6.48(dd, 1H) | 7.25(d, 1H) | 7.54(t, 1H) | 7.26(ddd, 1H) | ― |
15 | 7.58(dd, J=8.1, 1.3 Hz, 1H) | 7.58(td, 1H) | 7.37(ddd, 1H) | 8.13(d, 1H) | 8.04(m, 1H) | 7.68(dd, 1H) | ― |
18 | 4.42—4.59(d, J=16.9 Hz, 1H) | 4.40—4.48 (d, 2H) | 4.26—4.34 (d, 2H) | 4.55—4.40 (m, 2H) | 11.88(s, 1H) | 3.60(s, 3H) | ― |
20 | 1.96(s, 3H) | 1.95(s, 3H) | 1.88(s, 3H) | 1.97(s, 3H) | ― | ― | ― |
Table 5 1H NMR data of aranidipine and its impurities
Positiona | Aranidipineb | Ara?ox Ⅰb | Ara?ox Ⅱb | Ara?ox Ⅲb | Ara?cidc | Ara?bisb | Ara?1b |
---|---|---|---|---|---|---|---|
3 | 6.50(s, 1H) | ― | ― | ― | 8.96(s, 1H) | 5.99(s, 1H) | 2.51(s, 3H) |
4 | ― | ― | ― | ― | ― | ― | 8.25(dd, 1H) |
6 | 5.68(s, 1H) | ― | ― | ― | 5.00(s, 1H) | 5.73(s, 1H) | 7.60(dddd, 1H) |
7 | 2.23(s, 3H) | 2.58(s, 3H) | 2.60(s, 3H) | 2.53(s, 3H) | 2.29(d, 3H) | 2.34(s, 3H) | 7.48—7.41(m, 1H) |
8 | 2.27(s, 3H) | 2.68(s, 3H) | 2.71(s, 3H) | 2.65(s, 3H) | 2.29(d, 3H) | 2.34(s, 3H) | 8.10(s, 1H) |
10 | 3.50(s, 3H) | 3.42(s, 3H) | 3.31(s, 3H) | 3.44(s, 3H) | 3.56(s, 3H) | 3.60(s, 3H) | 7.68(td, 1H) |
12 | 7.45(dd, J=7.9, 1.6 Hz, 1H) | 8.13(dd, 1H) | 7.65(td, 1H) | 7.57(dt, 1H) | 7.97(m, 1H) | 7.58(m, 1H) | 3.62(s, 3H) |
13 | 7.40(td, J=8.0, 7.5, 1.4 Hz, 1H) | 7.50(td, 1H) | 7.48(dd, 1H) | 7.57(dt, 1H) | 7.60(dt, 1H) | 7.41(m, 1H) | ― |
14 | 7.22—7.14(m, 1H) | 7.17(dd, 1H) | 6.48(dd, 1H) | 7.25(d, 1H) | 7.54(t, 1H) | 7.26(ddd, 1H) | ― |
15 | 7.58(dd, J=8.1, 1.3 Hz, 1H) | 7.58(td, 1H) | 7.37(ddd, 1H) | 8.13(d, 1H) | 8.04(m, 1H) | 7.68(dd, 1H) | ― |
18 | 4.42—4.59(d, J=16.9 Hz, 1H) | 4.40—4.48 (d, 2H) | 4.26—4.34 (d, 2H) | 4.55—4.40 (m, 2H) | 11.88(s, 1H) | 3.60(s, 3H) | ― |
20 | 1.96(s, 3H) | 1.95(s, 3H) | 1.88(s, 3H) | 1.97(s, 3H) | ― | ― | ― |
Positiona | Aranidipineb | Ara?ox Ⅰb | Ara?ox Ⅱb | Ara?ox Ⅲb | Ara?acidc | Ara?bisb | Ara?1b |
---|---|---|---|---|---|---|---|
1 | 101.96(C) | 123.76(C) | 127.41(C) | 124.65(C) | 102.15(C) | 103.61(C) | 133.91(C) |
2 | 147.79(C) | 157.59(C) | 157.04(C) | 149.01(C) | 148.13(C) | 147.87(C) | 194.49(C) |
3 | ― | ― | ― | ― | ― | ― | 27.12(CH3) |
4 | 147.14(C) | 157.36(C) | 156.77(C) | 148.64(C) | 150.48(C) | 147.87(C) | 140.44(CH) |
5 | 103.92(C) | 124.37(C) | 128.96(C) | 124.65(C) | 100.82(C) | 103.61(C) | 166.31(C) |
6 | 34.53(CH) | 147.64(C) | 144.69(C) | 133.08(C) | 39.44(CH) | 34.55(CH) | 136.27(CH) |
7 | 19.23(CH3) | 23.69(CH3) | 23.53(CH3) | 16.50(CH3) | 18.67(CH3) | 19.47(CH3) | 129.89(CH) |
8 | 19.40(CH3) | 23.96(CH3) | 23.76(CH3) | 16.50(CH3) | 18.74(CH3) | 19.47(CH3) | 125.16(CH) |
9 | 166.34(C) | 166.08(C) | 166.50(C) | 164.06(C) | 167.57(C) | 167.61(C) | 147.01(C) |
10 | 51.02(CH3) | 52.21(CH3) | 52.08(CH3) | 52.72(CH3) | 51.25(CH3) | 51.05(CH3) | 130.61(CH) |
11 | 144.94(C) | 132.98(C) | 139.69(C) | 131.77(C) | 146.22(C) | 142.17(C) | 130.35(C) |
12 | 131.34(CH) | 130.95(CH) | 135.08(CH) | 130.63(CH) | 130.08(CH) | 131.07(CH) | 52.33(CH3) |
13 | 132.90(CH) | 129.63(CH) | 130.90(CH) | 128.78(CH) | 134.43(CH) | 132.78(CH) | ― |
14 | 127.11(CH) | 131.69(CH) | 135.08(CH) | 130.18(CH) | 121.98(CH) | 127.07(CH) | ― |
15 | 123.83(CH) | 124.90(CH) | 107.90(CH) | 127.81(CH) | 121.55(CH) | 123.91(CH) | ― |
Positiona | Aranidipineb | Ara?ox Ⅰb | Ara?ox Ⅱb | Ara?ox Ⅲb | Ara?acidc | Ara?bisb | Ara?1b |
16 | 142.25(C) | 145.47(C) | 161.72(C) | 147.98(C) | 147.29(C) | 145.03(CH) | ― |
17 | 167.45(C) | 167.25(C) | 167.66(C) | 165.25(C) | 168.87(C) | 167.61(C) | ― |
18 | 67.82(CH2) | 68.80(CH2) | 68.72(CH2) | 69.10(CH3) | ― | 51.05(CH3) | ― |
19 | 203.18(C) | 199.49(C) | 199.69((C)) | 198.78(C) | ― | ― | ― |
20 | 25.84(CH3) | 25.83(CH3) | 25.84(CH3) | 25.76(CH3) | ― | ― | ― |
Table 6 13C NMR data of aranidipine and its impurities
Positiona | Aranidipineb | Ara?ox Ⅰb | Ara?ox Ⅱb | Ara?ox Ⅲb | Ara?acidc | Ara?bisb | Ara?1b |
---|---|---|---|---|---|---|---|
1 | 101.96(C) | 123.76(C) | 127.41(C) | 124.65(C) | 102.15(C) | 103.61(C) | 133.91(C) |
2 | 147.79(C) | 157.59(C) | 157.04(C) | 149.01(C) | 148.13(C) | 147.87(C) | 194.49(C) |
3 | ― | ― | ― | ― | ― | ― | 27.12(CH3) |
4 | 147.14(C) | 157.36(C) | 156.77(C) | 148.64(C) | 150.48(C) | 147.87(C) | 140.44(CH) |
5 | 103.92(C) | 124.37(C) | 128.96(C) | 124.65(C) | 100.82(C) | 103.61(C) | 166.31(C) |
6 | 34.53(CH) | 147.64(C) | 144.69(C) | 133.08(C) | 39.44(CH) | 34.55(CH) | 136.27(CH) |
7 | 19.23(CH3) | 23.69(CH3) | 23.53(CH3) | 16.50(CH3) | 18.67(CH3) | 19.47(CH3) | 129.89(CH) |
8 | 19.40(CH3) | 23.96(CH3) | 23.76(CH3) | 16.50(CH3) | 18.74(CH3) | 19.47(CH3) | 125.16(CH) |
9 | 166.34(C) | 166.08(C) | 166.50(C) | 164.06(C) | 167.57(C) | 167.61(C) | 147.01(C) |
10 | 51.02(CH3) | 52.21(CH3) | 52.08(CH3) | 52.72(CH3) | 51.25(CH3) | 51.05(CH3) | 130.61(CH) |
11 | 144.94(C) | 132.98(C) | 139.69(C) | 131.77(C) | 146.22(C) | 142.17(C) | 130.35(C) |
12 | 131.34(CH) | 130.95(CH) | 135.08(CH) | 130.63(CH) | 130.08(CH) | 131.07(CH) | 52.33(CH3) |
13 | 132.90(CH) | 129.63(CH) | 130.90(CH) | 128.78(CH) | 134.43(CH) | 132.78(CH) | ― |
14 | 127.11(CH) | 131.69(CH) | 135.08(CH) | 130.18(CH) | 121.98(CH) | 127.07(CH) | ― |
15 | 123.83(CH) | 124.90(CH) | 107.90(CH) | 127.81(CH) | 121.55(CH) | 123.91(CH) | ― |
Positiona | Aranidipineb | Ara?ox Ⅰb | Ara?ox Ⅱb | Ara?ox Ⅲb | Ara?acidc | Ara?bisb | Ara?1b |
16 | 142.25(C) | 145.47(C) | 161.72(C) | 147.98(C) | 147.29(C) | 145.03(CH) | ― |
17 | 167.45(C) | 167.25(C) | 167.66(C) | 165.25(C) | 168.87(C) | 167.61(C) | ― |
18 | 67.82(CH2) | 68.80(CH2) | 68.72(CH2) | 69.10(CH3) | ― | 51.05(CH3) | ― |
19 | 203.18(C) | 199.49(C) | 199.69((C)) | 198.78(C) | ― | ― | ― |
20 | 25.84(CH3) | 25.83(CH3) | 25.84(CH3) | 25.76(CH3) | ― | ― | ― |
Compd. | IR, |
---|---|
Aranidipine | 3330(νNH, NH), 3100—3000(νArH, phenyl), 2950(νCH, CH3), 1710(νC=O, ketocarbonyl), 1679(νC=O, ester carbonyl), 1643, 1619, 1494(νC=C, phenyl and DHPR), 1525, 1349(νasNO2+νsNO2, Ar—NO2), 1430(δCH2, O—CH2), 1382(δCH3, CH3), 1203(νC—O, ester), 715(δArH, 1,2?substituted phenyl) |
Ara?ox Ⅰ | 3100—3000(νArH, phenyl), 2952(νCH, CH3), 1741(νC=O, ketocarbonyl), 1725(νC=O, ester carbonyl), 1556, 1438(νC=C, phenyl and Pyridine), 1531, 1351(νasNO2+νsNO2, Ar—NO2), 1423(δCH2, O—CH2), 1373(δCH3, CH3), 1236(νC—O, ester), 705(δArH, 1,2?substituted phenyl) |
Ara?ox Ⅱ | 3100—3000(νArH, phenyl), 2950(νCH, CH3), 1745(νC=O, ketocarbonyl), 1724(νC=O, ester carbonyl), 1560, 1436(νC=C, phenyl and pyridine), 1500(νNO, Ar—NO), 1421(δCH2, O—CH2), 1374(δCH3, CH3), 1241(νC—O, ester), 775(δArH, 1,2?substituted phenyl) |
Ara?ox Ⅲ | 3100—3000(νArH, phenyl), 2954(νCH, CH3), 1739(νC=O ketocarbonyl), 1725(νC=O, ester carbonyl), 1436(νC=C, phenyl and pyridine), 1529, 1349((νasNO2+νsNO2, Ar—NO2), 1419(δCH2, O—CH2), 1349(δCH3, CH3), 1299(νN—O, nitrogen), 1241(νC—O, ester), 705(δArH, 1,2?substituted phenyl) |
Ara?acid | 3342(νNH, NH), 3100—3000(νArH, phenyl), 2964(νCH, CH3), 1662(νC=O, ester carbonyl), 1606, 1477(νC=C, phenyl and pyridine), 1529, 1344(νasNO2+νsNO2, Ar—NO2), 1315(δCH3, CH3), 1230(νC—O, ester), 705(δArH, 1,2?substituted phenyl) |
Ara?bis | 3330(νNH, NH), 3100—3000(νArH, phenyl), 2952(νCH, CH3), 1679(νC=O, ester carbonyl), 1646, 1496, 1439(νC=C, phenyl and pyridine), 1529, 1349(νasNO2+νsNO2, Ar—NO2), 1309(δCH3, CH3), 1120, 1101, 1022(νC—O, ester), 713(δArH, 1,2?substituted phenyl) |
Ara?1 | 2932(νCH, CH3), 1726(νC=O, ketocarbonyl), 1672(νC=O, ester carbonyl), 1438(νC=C, phenyl and pyridine), 1531, 1351(νasNO2+νsNO2, Ar—NO2), 1391(δCH3, CH3), 1236(νC—O, ester), 750(δArH, 1,2?substituted phenyl) |
Table 7 Data of IR analysis of aranidipine and its impurities
Compd. | IR, |
---|---|
Aranidipine | 3330(νNH, NH), 3100—3000(νArH, phenyl), 2950(νCH, CH3), 1710(νC=O, ketocarbonyl), 1679(νC=O, ester carbonyl), 1643, 1619, 1494(νC=C, phenyl and DHPR), 1525, 1349(νasNO2+νsNO2, Ar—NO2), 1430(δCH2, O—CH2), 1382(δCH3, CH3), 1203(νC—O, ester), 715(δArH, 1,2?substituted phenyl) |
Ara?ox Ⅰ | 3100—3000(νArH, phenyl), 2952(νCH, CH3), 1741(νC=O, ketocarbonyl), 1725(νC=O, ester carbonyl), 1556, 1438(νC=C, phenyl and Pyridine), 1531, 1351(νasNO2+νsNO2, Ar—NO2), 1423(δCH2, O—CH2), 1373(δCH3, CH3), 1236(νC—O, ester), 705(δArH, 1,2?substituted phenyl) |
Ara?ox Ⅱ | 3100—3000(νArH, phenyl), 2950(νCH, CH3), 1745(νC=O, ketocarbonyl), 1724(νC=O, ester carbonyl), 1560, 1436(νC=C, phenyl and pyridine), 1500(νNO, Ar—NO), 1421(δCH2, O—CH2), 1374(δCH3, CH3), 1241(νC—O, ester), 775(δArH, 1,2?substituted phenyl) |
Ara?ox Ⅲ | 3100—3000(νArH, phenyl), 2954(νCH, CH3), 1739(νC=O ketocarbonyl), 1725(νC=O, ester carbonyl), 1436(νC=C, phenyl and pyridine), 1529, 1349((νasNO2+νsNO2, Ar—NO2), 1419(δCH2, O—CH2), 1349(δCH3, CH3), 1299(νN—O, nitrogen), 1241(νC—O, ester), 705(δArH, 1,2?substituted phenyl) |
Ara?acid | 3342(νNH, NH), 3100—3000(νArH, phenyl), 2964(νCH, CH3), 1662(νC=O, ester carbonyl), 1606, 1477(νC=C, phenyl and pyridine), 1529, 1344(νasNO2+νsNO2, Ar—NO2), 1315(δCH3, CH3), 1230(νC—O, ester), 705(δArH, 1,2?substituted phenyl) |
Ara?bis | 3330(νNH, NH), 3100—3000(νArH, phenyl), 2952(νCH, CH3), 1679(νC=O, ester carbonyl), 1646, 1496, 1439(νC=C, phenyl and pyridine), 1529, 1349(νasNO2+νsNO2, Ar—NO2), 1309(δCH3, CH3), 1120, 1101, 1022(νC—O, ester), 713(δArH, 1,2?substituted phenyl) |
Ara?1 | 2932(νCH, CH3), 1726(νC=O, ketocarbonyl), 1672(νC=O, ester carbonyl), 1438(νC=C, phenyl and pyridine), 1531, 1351(νasNO2+νsNO2, Ar—NO2), 1391(δCH3, CH3), 1236(νC—O, ester), 750(δArH, 1,2?substituted phenyl) |
1 | Kanda A., Haruno A., Miyake H., Nagasaka M., J. Cardiovasc. Pharmacol., 1992, 20(5), 723—730 |
2 | Masumiya H., Tanaka Y., Tanaka H., Shigenobu K., Pharmacology, 2000, 61(2), 57—61 |
3 | Miyoshi K., Kanda A., Miyake H., Ichihara K., Kamei H., Nagasaka M., Eur. J. Pharmacol., 1993, 238(2/3), 139—148 |
4 | Miyoshi K., Miyake H., Ichihara K., Kamei H., Nagasaka M., Naunyn⁃Schmiedeberg’s Arch. Pharmacol., 1996, 355(1), 119—125 |
5 | Ohno S., Komatsu O., Mizukoshi K., Ichihara K., Nakamura Y., Morishima T., Sumita K., Chem. Pharm. Bull., 1986, 34(4), 1589—1606 |
6 | Chen G. P., Xia F. F., Du C. M., Chen L. Q., Wang X., Zhang L., A Method of Preparing Are Leveled, CN 104557678, 2015⁃04⁃29 (陈国平, 夏方方, 杜成铭, 陈丽庆, 王霞, 张梁. 一种制备阿雷地平的方法, CN 104557678, 2015⁃04⁃29) |
7 | Ohno S., Mizukoshi K., Komatsu O., 1,4⁃Dihydropyridine Compounds, US 4446325, 1984⁃05⁃01 |
8 | Li L., Luo Z. F., Ding Y., Chin. J. Pharm., 2008, 39(1), 6—8(李玲, 罗振福, 丁一. 中国医药工业杂志, 2008, 39(1), 6—8) |
9 | Zhao R., Synthesis of Aranidipine, Tianjin University of Technology, Tianjin, 2010(赵蕊. 阿雷地平的合成研究, 天津: 天津理工大学, 2010) |
10 | Tang L., Wang J. T., Zhang J. Q., Mao Y. H., A Kind of Preparation Method of Barnidipine Key Intermediate, CN 110283118, 2019⁃09⁃27(汤磊, 王建塔, 张吉泉, 毛远湖. 一种巴尼地平关键中间体的制备方法, CN 110283118, 2019⁃09⁃27) |
11 | Zhang M., Preparation Method of Key Intermediate of Dihydropyridine Calcium Channel Antagonist and Synthesis of Clevidipine Butyrate, CN 102675189A, 2012⁃09⁃19(张明. 二氢吡啶类钙通道拮抗剂关键中间体的制备方法以及丁酸氯维地平的合成, CN 102675189A, 2012⁃09⁃19) |
12 | Luo L., Mu X. Q., Wu T., Nie Y., Xu Y., Chem.J. Chinese Universities, 2021, 42(8), 2458—2464(罗磊, 穆晓清, 吴涛, 聂尧, 徐岩. 高等学校化学学报, 2021, 42(8), 2458—2464) |
13 | Wang S. B., Wu X. M., Wu J. M., Tang Y. F., Shu C., Zhong M., Huang W., Yan D.Y., Chem. J. Chinese Universities, 2021, 42(9), 2944—2952(王寿柏, 吴修明, 吴锦明, 汤艳峰, 束辰, 钟敏, 黄卫, 颜德岳. 高等学校化学学报, 2021, 42(9), 2944—2952) |
14 | Kundu B., Tetrahedron Lett., 1992, 33(22), 3193—3196 |
15 | Lillington J. M., Trafford D. J., Makin H. L., Int. J. Clin. Chem, 1981, 111(1), 91—98 |
16 | Wang L. J., Tian Y., Zhang Z. J., Chin. J. Pharm. Anal., 2018, 38(12), 2024—2053(王丽娟, 田媛, 张尊建. 药物分析杂志, 2018, 38(12), 2045—2053) |
17 | Leonardi A., Motta G., Nardi D., Eur. J. Med. Chem., 1998, 33(5), 399—420 |
18 | Sadana G. S., Ghogare A. B., Int. J. Pharm., 1991, 70(1/2), 195—199 |
19 | Marciniec B., Ogrodowczyk M., Acta Pol. Pharm., 2006, 63(6), 477—484 |
20 | Vidal S., Court J., Bonnier J. M., J. Chem. Soc. Perkin Trans., 2, 1982, (6), 663—667 |
21 | Li K., Du Y. M., Wang H. R., Chin. J. Pharm., 2006, 37(3), 153—154(李坤, 杜玉民, 王海荣. 中国医药工业杂志, 2006, 37(3), 153—154) |
22 | Li G. C., Tian Y., Li C. X., Wu C. Z., Niu L. F., Ju Z. Y., Su T., Zhejiang Chem. Ind., 2015, 46(03), 26—29(李公春, 田源, 李存希, 吴长增, 牛亮峰, 鞠志宇, 孙婷. 浙江化工, 2015, 46(03), 26—29) |
23 | Scherling D., Pleib U., J. Labelled. Compd. Radiopharm., 1988, 25(12), 1393—1400 |
24 | Litvic M., Filipan M., Pogorelic I., Cepanec I., Green Chem., 2005, 7(11), 771—774 |
25 | Chandrasekaran S., Kluge A. F., Edwards J. A., J. Org. Chem., 1977, 42(24), 3972—3974 |
26 | Mehta A., Jaouhari R., Benson T. J., Douglas K. T., Tetrahedron Lett., 1992, 33(37), 5441—5444 |
27 | Strazzolini P., Misuri N., Polese P., Tetrahedron Lett., 2005, 46(12), 2075—2078 |
28 | Fu P., Su W., Wang X. Y., Li J., Sun Y., Fine Chem., 2021, 38(05), 1068—1073 |
29 | Zhang B., The Synthesis of Nimodipine Impurity in EP and the Process Control of Impurity, Shandong University, Jinan, 2012(张博. 尼莫地平欧洲药典杂质合成与生产过程杂质控制, 济南: 山东大学, 2012) |
30 | Lu J., Bai Y. J., Yang B. Q., Ma H. R., Chin. J. Org. Chem., 2000,20(4), 514—517 |
31 | Raju C. K., Kumar J. V. S., Palusa S. K. G., New J. Chem., 2018, 42(1), 634—646 |
[1] | 汪明芳, 付华, 付志博, 王月荣, 章弘扬, 张敏, 胡坪. 聚合物共混物的超高效液相色谱-空间排阻色谱在线联用分离与表征[J]. 高等学校化学学报, 2022, 43(4): 20210865. |
[2] | 史歌, 徐茜, 代枭, 张洁, 沈军, 宛新华. 芳香取代基结构对螺旋聚乙炔高效液相色谱手性固定相手性识别性能的影响[J]. 高等学校化学学报, 2021, 42(8): 2673. |
[3] | 潘梦芸, 冯流星, 李红梅. 高效液相色谱-非特异性同位素稀释质谱联用技术定量分析全血中总血红蛋白含量[J]. 高等学校化学学报, 2020, 41(9): 1983. |
[4] | 何聿, 夏倩, 王文莉, 罗芳, 陈金凤, 郭雅婷, 王建, 林振宇, 陈国南. UPLC-QTOF-MS法研究甘油三酯作为水生环境中农药污染的潜在生物标志物[J]. 高等学校化学学报, 2020, 41(3): 431. |
[5] | 王天琦,余琼卫,冯钰锜. 基于氧化镍沉积硅胶固相萃取与液相色谱-质谱联用技术的2型糖尿病血清中咪唑丙酸的检测[J]. 高等学校化学学报, 2020, 41(2): 262. |
[6] | 张辉, 张晨杰, 徐敏敏, 袁亚仙, 姚建林. SERS-HPLC联用技术对邻氨基苯硫酚与邻碘苯甲酰氯反应的监测[J]. 高等学校化学学报, 2020, 41(11): 2496. |
[7] | 赵孟欣, 孟哲, 李和平, 马宗琴, 詹海鹃, 刘万毅. 氧化石墨烯调控钼酸铋在可见光下选择性光催化降解环境水中的抗生素[J]. 高等学校化学学报, 2020, 41(11): 2479. |
[8] | 杜晨晖, 李泽, 崔小芳, 张敏, 裴香萍, 詹海仙, 闫艳. 基于UPLC-Q-Orbitrap MS/MS技术研究酸枣仁发酵过程中的化学成分转化[J]. 高等学校化学学报, 2019, 40(8): 1614. |
[9] | 赵幻希, 王秋颖, 孙秀丽, 李雪, 苗瑞, 吴冬雪, 刘淑莹, 修洋. HPLC-MS结合多元统计分析区分人参产地及筛选皂苷类标志物[J]. 高等学校化学学报, 2019, 40(2): 246. |
[10] | 周敏, 徐小英, 龙远德. 羧甲基-β-环糊精手性固定相拆分17种β-内酰胺及其机理[J]. 高等学校化学学报, 2018, 39(6): 1164. |
[11] | 丘秀珍, 华永标, 郭会时, 卢文贯. 分子印迹纳米管膜的制备及对人体尿液中儿茶酚胺类药物的检测[J]. 高等学校化学学报, 2018, 39(4): 653. |
[12] | 苗瑞, 吴冬雪, 王秋颖, 赵幻希, 李雪, 修洋, 刘淑莹. 基于多壁碳纳米管的人参皂苷快速分离[J]. 高等学校化学学报, 2018, 39(10): 2178. |
[13] | 黄玉, 谷彩云, 吴翰钟, 夏晓爽, 李新. 基于超高效液相色谱-四极杆飞行时间质谱的缺血性脑卒中的代谢组学研究[J]. 高等学校化学学报, 2017, 38(10): 1742. |
[14] | 唐徐情, 任秀斌, 陆海彦, 林海波, 王超男, 刘红红, 刘守信. 镀液中金属杂质离子对电镀镍层性能的影响[J]. 高等学校化学学报, 2016, 37(7): 1364. |
[15] | 农蕊瑜, 孔娇, 章俊辉, 陈玲, 汤波, 谢生明, 袁黎明. 手性金属-有机骨架材料{[Co(L-trp)(bpe)(H2O)]·H2O·NO3}n用于高效液相色谱的拆分性能[J]. 高等学校化学学报, 2016, 37(1): 19. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||